| Information for
patients
|
| Drug Information |
Abdominal distention, upper abdominal distress, heartburn, belching and vomiting |
| Drug Alert |
| Alert |
Should be use with caution in patients receiving antihypertensive, hypnotic and analgesic drugs, because concurrent use may increase the effects of these drugs. |
| Before Consuming
the Medicine
|
| Avoid Drug |
Phaeochromocytoma, epilepsy, manic states, hyperprolactinaemia, mammary dysplasia, malignant mastopathies, cardiac impairment. GI bleeding, mechanical obstruction or perforation. |
| Drug Special Care |
Hypersensitivity to sulpiride
Pre-existing breast cancer or other prolactin-dependent tumors
Phaeochromocytoma
Intoxication with other centrally active drugs
Concomitant use of levodopa
Pre-existing Parkinson's Disease
Patients below 18 years of age (insufficient clinical data)
Pre-existing severe heart disease/bradycardia, or hypokalemia (predisposing to long QT syndrome and severe arrhythmias)
Patients with pre-existing epilepsy. Anticonvulsant therapy should be maintained. |
| Drug Drug Interactions |
Reduced bioavailability with sucralfate, aluminium- and magnesium-containing antacids. Effect on GI motility may be antagonised by anticholinergic agents, narcotics and analgesics. Avoid alcohol. |
| Drug Pregnancy Interaction |
Pregnancy: Animal studies did not reveal any embryotoxicity or fetotoxicity, nor did limited human experience. Due to insufficient human data, pregnant women should be treated with sulpiride only if strictly indicated. Additionally, the newborns of treated women should be monitored, because isolated cases of extrapyramidal side effects have been reported. |
| Drug Breast feeding Interaction |
Lactation: Sulpiride is found in the milk of lactating women. Since the consequences are unclear, women should not breastfeed during treatment. |
| Drug Machinery Interaction |
|
| Drug More Information |
|
| How to take the
Medicine
|
| Consumption Info |
|
| Drug quanitty |
Schizophrenia 200-300 mg/day. Dyspeptic syndrome; Functional dyspepsia; GERD; Irritable bowel syndrome; Cytotoxic-induced nausea and vomiting; Vasomotor headache; Vertigo 25 mg 3 times/day. IV Cytotoxic-induced nausea and vomiting 25-50 mg 30 min prior, during and 30 mins after end of chemotherapy. IV/IM Dyspeptic syndrome; Functional dyspepsia; Nausea and vomiting due to motility disorders; Vasomotor headache; Vertigo 25 mg 2-3 times/day |
| Drug Dose |
|
| Excess Drug Consumption |
Sulpiride has a relatively low order of acute toxicity. Substantial amounts may cause severe but reversible dystonic crises with torticollis, protrusion of the tongue, and/or trismus. In some cases all the classical symptoms typical of severe Parkinson's Disease may be noted; in others, over-sedation/coma may occur. The treatment is largely symptomatic. Some or all extrapyramidal reactions may respond to the application of anticholinergic drugs such as biperiden or benztropine. All patients should be closely monitored for signs of long-QT syndrome and severe arrhythmias. |
| Forgot Drug Consumption |
|
| Stop Drug Consumption |
|
| Possible Side
Effects
|
| General Information |
Amenorrhoea, gynaecomastia, galactorrhoea, changes in libido.
Potentially Fatal: Neuroleptic malignant syndrome. |
| Common Drug Side Effects |
|
| Rare Drug Side Effects |
|
| Very Rare Drug Side Effects |
|
| Drug Side Effects Symptoms |
|
| How to Store the
Medicine
|
| How to Store the Medicine |
Store at 15-30°C (59-86°F). |
Sign In
Create New Account